Brief: Transmedics Receives FDA Ide Approval To Initiate Next-Generation Ocs Heart Trial
04/08/2025 13:48
Aug 4 (Reuters) - Transmedics Group Inc TMDX.O: TRANSMEDICS RECEIVES FDA IDE APPROVAL TO INITIATE NEXT-GENERATION OCS HEART TRIAL Source text: ID:nPnHp86a Further company coverage: TMDX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on TransMedics
See all newsBrief: TransMedics Appoints Fernando Araujo As Chief Financial Officer And Reiterates 2026 Financial Outlook
Transmedics Group Inc reports results for the quarter ended June 30 - Earnings Summary
TransMedics Q2 net income declines on R&D and infrastructure expenses
Brief: Transmedics Group Q2 EPS USD 0.41
TransMedics Q1 revenue edges past estimates